HOME >> BIOLOGY >> NEWS
Dogs itching to try homeopathic remedies

Dogs with a common allergic skin disease, canine atopic dermatitis, will be taking part in a clinical trial to evaluate the effectiveness of homeopathic remedies as conventional meets complementary at Bristol University's School of Veterinary Science.

Dr Peter Hill, Senior Lecturer in Veterinary Dermatology at Bristol's Vet School is embarking on the trial that aims to settle some of the arguments about the practice of homeopathy. The trial is only possible due to collaboration with one of the UK's best-known homeopathic veterinary surgeons, Mr John Hoare, and Dr Robert Mathie, Research Development Adviser at the British Homeopathic Association and Faculty of Homeopathy.

The practice of homeopathy is currently under great scrutiny in both the medical and veterinary fields. On the one hand, conventional medical practice would dictate that the principle on which homeopathy is based has no grounding in science and amounts to nothing more than sheer fantasy. Any response to treatment is discounted as pure placebo effect. On the other hand, trained homeopaths maintain that their system, although not fully understood from a pharmacological point of view, yields genuine therapeutic results, often after conventional medicines have failed. Such views are supported by a small but growing body of published research.

During the trial, the dermatologists at Bristol's Vet School and Mr Hoare will be working in tandem. The dermatologists will be responsible for making the initial diagnosis and objectively assessing the response to treatment. Mr Hoare will be responsible for prescribing the homeopathic remedies, after evaluating the dog's symptoms and various aspects of its personality. The trial will be conducted in two phases.

Phase one, which is really intended to establish proof of principle, is an open clinical trial in which the main measure of assessment will be the level of itching. If this phase proves that homeopathy appea
'"/>

Contact: Joanne Fryer
joanne.fryer@bristol.ac.uk
44-117-331-7276
University of Bristol
19-Jul-2006


Page: 1 2

Related biology news :

1. Structural basis for photoswitching in fluorescent proteins brought into focus
2. Switching genes to overdrive improves muscular dystrophy symptoms in mice
3. Switching to new anti-bacterial targets: Riboswitches
4. OHSU study: Bacterial switching mechanism key to survival
5. Plants management of nutrient suggests environmental remedies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... Catalent, the ... biologics, cell and gene therapies, and consumer health products, today announced that two ... Conference & Expo, taking place between Aug. 31 – September 4, 2020. , ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., a ... U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New Drug ... of severe COVID-19. Approval of this IND allows Sentien to initiate a Phase ...
(Date:8/21/2020)... ... August 20, 2020 , ... NDA Partners Chairman Carl ... executive with expertise in clinical trial planning and feasibility, regulatory inspection readiness, and ... Throughout his career, Mr. Movahhed has helped design and manage oncology, neurology, cardiovascular, ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... Slone ... companies, has announced the placement of Julianne Averill , CPA, as Chief ... all financial operations and implementing key business strategies to accelerate Alveo’s growth as ...
(Date:8/15/2020)... ... ... True Terpenes , the leading platform for terpene innovation, research and ... the medical potential of terpenes and the potential entourage effect , where the ... focused on expanding the recently launched line of effects-based terpenes - Terpology by ...
(Date:8/12/2020)... , ... August 11, 2020 , ... ... year to expand the Facioscapulohumeral Muscular Dystrophy Clinical Trial Research Network ... and 2022. The network is a consortium of academic research centers in the ...
(Date:8/12/2020)... ... August 12, 2020 , ... ... International), a global leader in FDA compliance consulting has been named on its ... companies. The list represents a unique look at the most successful companies within ...
Breaking Biology Technology:
Cached News: